Rocky Baker
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 21 | 2026 | 1150 | 4.200 |
Why?
| | Autoantigens | 13 | 2026 | 426 | 3.050 |
Why?
| | Insulin | 13 | 2026 | 2525 | 2.550 |
Why?
| | Diabetes Mellitus, Type 1 | 24 | 2026 | 3930 | 2.520 |
Why?
| | Chromogranin A | 7 | 2024 | 43 | 1.540 |
Why?
| | C-Peptide | 6 | 2025 | 191 | 1.500 |
Why?
| | Islets of Langerhans | 8 | 2026 | 852 | 1.290 |
Why?
| | Mice, Inbred NOD | 18 | 2026 | 598 | 1.230 |
Why?
| | Peptide Fragments | 7 | 2026 | 693 | 1.180 |
Why?
| | Peptides | 10 | 2026 | 992 | 1.170 |
Why?
| | Islet Amyloid Polypeptide | 4 | 2018 | 48 | 1.110 |
Why?
| | T-Lymphocytes | 4 | 2025 | 2012 | 0.920 |
Why?
| | Immune Tolerance | 3 | 2026 | 386 | 0.860 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2021 | 175 | 0.690 |
Why?
| | Autoimmunity | 7 | 2022 | 925 | 0.690 |
Why?
| | CD40 Antigens | 2 | 2012 | 69 | 0.620 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2021 | 677 | 0.610 |
Why?
| | Autoantibodies | 1 | 2025 | 1500 | 0.520 |
Why?
| | Recombination, Genetic | 1 | 2018 | 202 | 0.500 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2021 | 198 | 0.490 |
Why?
| | Mice | 20 | 2026 | 18297 | 0.440 |
Why?
| | CD40 Ligand | 2 | 2012 | 32 | 0.430 |
Why?
| | Lymphocyte Activation | 4 | 2018 | 1137 | 0.400 |
Why?
| | Islets of Langerhans Transplantation | 2 | 2026 | 72 | 0.390 |
Why?
| | Epitopes | 5 | 2024 | 479 | 0.360 |
Why?
| | Animals | 22 | 2026 | 38107 | 0.340 |
Why?
| | Prediabetic State | 1 | 2013 | 250 | 0.310 |
Why?
| | Cells, Cultured | 7 | 2019 | 4118 | 0.300 |
Why?
| | Immunotherapy | 3 | 2026 | 671 | 0.290 |
Why?
| | Adoptive Transfer | 3 | 2015 | 197 | 0.290 |
Why?
| | Cathepsin D | 2 | 2026 | 22 | 0.290 |
Why?
| | Proinsulin | 2 | 2026 | 54 | 0.290 |
Why?
| | Clone Cells | 3 | 2018 | 259 | 0.250 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2018 | 58 | 0.230 |
Why?
| | Amino Acid Sequence | 3 | 2026 | 2092 | 0.230 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2026 | 931 | 0.220 |
Why?
| | Antigens, CD | 1 | 2008 | 560 | 0.220 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 393 | 0.220 |
Why?
| | Mice, SCID | 2 | 2018 | 360 | 0.210 |
Why?
| | Mice, Knockout | 4 | 2021 | 3125 | 0.190 |
Why?
| | Graft Survival | 2 | 2026 | 523 | 0.190 |
Why?
| | Protein Processing, Post-Translational | 1 | 2026 | 487 | 0.190 |
Why?
| | HLA-DQ Antigens | 2 | 2021 | 171 | 0.180 |
Why?
| | Flow Cytometry | 3 | 2015 | 1163 | 0.170 |
Why?
| | K562 Cells | 1 | 2021 | 93 | 0.170 |
Why?
| | Protein Array Analysis | 1 | 2021 | 56 | 0.160 |
Why?
| | Female | 10 | 2026 | 79499 | 0.160 |
Why?
| | HLA-DRB1 Chains | 1 | 2020 | 109 | 0.150 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2019 | 127 | 0.140 |
Why?
| | Crosses, Genetic | 1 | 2018 | 120 | 0.140 |
Why?
| | Humans | 12 | 2026 | 146342 | 0.140 |
Why?
| | Immune System | 1 | 2019 | 181 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2012 | 2623 | 0.130 |
Why?
| | Nanoparticles | 2 | 2022 | 523 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 1 | 2019 | 663 | 0.120 |
Why?
| | Mice, Inbred BALB C | 2 | 2016 | 1244 | 0.120 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 585 | 0.120 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 415 | 0.110 |
Why?
| | Young Adult | 2 | 2025 | 14330 | 0.110 |
Why?
| | Microsatellite Repeats | 1 | 2015 | 159 | 0.110 |
Why?
| | Autoimmune Diseases | 1 | 2018 | 467 | 0.100 |
Why?
| | Adolescent | 3 | 2025 | 22557 | 0.100 |
Why?
| | Disease Progression | 2 | 2019 | 2867 | 0.100 |
Why?
| | Cell Proliferation | 2 | 2019 | 2502 | 0.100 |
Why?
| | Insulin, Regular, Human | 2 | 2024 | 47 | 0.100 |
Why?
| | Mice, Inbred C57BL | 2 | 2015 | 6034 | 0.100 |
Why?
| | Child | 3 | 2025 | 22693 | 0.100 |
Why?
| | CD4 Antigens | 1 | 2013 | 136 | 0.100 |
Why?
| | Male | 5 | 2025 | 73396 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 365 | 0.090 |
Why?
| | Transduction, Genetic | 1 | 2012 | 129 | 0.090 |
Why?
| | Spleen | 1 | 2013 | 503 | 0.080 |
Why?
| | Pancreas | 1 | 2013 | 343 | 0.080 |
Why?
| | Lymph Nodes | 1 | 2013 | 511 | 0.080 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 404 | 0.080 |
Why?
| | B-Lymphocytes | 1 | 2015 | 887 | 0.080 |
Why?
| | Adult | 3 | 2025 | 41087 | 0.080 |
Why?
| | CD28 Antigens | 1 | 2008 | 57 | 0.070 |
Why?
| | CTLA-4 Antigen | 1 | 2008 | 105 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 4340 | 0.060 |
Why?
| | Signal Transduction | 2 | 2012 | 5246 | 0.060 |
Why?
| | Up-Regulation | 1 | 2008 | 841 | 0.060 |
Why?
| | Interleukin-10 | 1 | 2026 | 310 | 0.050 |
Why?
| | Cell Line | 1 | 2008 | 2814 | 0.050 |
Why?
| | Middle Aged | 1 | 2025 | 36619 | 0.050 |
Why?
| | Transglutaminases | 2 | 2013 | 137 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2134 | 0.040 |
Why?
| | Cytoprotection | 1 | 2021 | 55 | 0.040 |
Why?
| | Proteomics | 2 | 2022 | 1203 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1512 | 0.040 |
Why?
| | Drug Liberation | 1 | 2021 | 36 | 0.040 |
Why?
| | Click Chemistry | 1 | 2021 | 54 | 0.040 |
Why?
| | Solubility | 1 | 2021 | 240 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2021 | 209 | 0.040 |
Why?
| | Remission Induction | 1 | 2021 | 308 | 0.040 |
Why?
| | Cross Reactions | 1 | 2020 | 130 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 1133 | 0.030 |
Why?
| | Animals, Genetically Modified | 1 | 2019 | 248 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2026 | 1982 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2019 | 209 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 377 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 781 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 2013 | 124 | 0.020 |
Why?
| | Primary Cell Culture | 1 | 2013 | 173 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 2012 | 131 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2016 | 2838 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 161 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1463 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4580 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2011 | 729 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 11821 | 0.010 |
Why?
|
|
Baker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|